TPCK (L-1-Tosylamido-2-phenylethyl chloromethyl ketone, L-TPCK) is an effective serine protease inhibitor and also a blocker of the PDK1/Akt pathway. TPCK can modify the E7 protein in actively keratinocyte cells. TPCK can induce cellular apoptosis, suppress tumor growth, reduce hypoxic-ischemic brain injury in rat pups, and affect vascular permeability in inflamed rats[1][2][3][4][5].
Molekulargewicht:
351.85
Reinheit:
99
CAS Nummer:
[402-71-1]
Formel:
C17H18ClNO3S
Target-Kategorie:
Apoptosis,HPV,PDK-1,Ser/Thr Protease
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten